Monopar Therapeutics
MNPR
MNPR
8 hedge funds and large institutions have $165K invested in Monopar Therapeutics in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
8
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$28K | |
| 2 | +$2.58K | |
| 3 | +$128 | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$4 |
Top Sellers
| 1 | -$51.5K | |
| 2 | -$32.6K | |
| 3 | -$8.88K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$7K |
| 5 |
JPMorgan Chase & Co
New York
|
-$3K |